8 Coupons
-
Special Offer
-
30% off
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.the daily californian covers the city of berkeley and the campus in unparalleled detail, all while training the future of the journalism industry. .
. home